OPC-21268, an orally effective, nonpeptide vasopressin V1 receptor antagonist

被引：0
|
作者：
机构：
来源：
| 1600年 / 252期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] EFFECTS OF THE NONPEPTIDE INHIBITOR OPC-21268 ON OXYTOCIN AND VASOPRESSIN STIMULATION OF RAT AND HUMAN MYOMETRIUM
    ATKE, A
    VILHARDT, H
    HAUZEROVA, L
    BARTH, T
    ANDERSEN, LF
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) : 63 - 68
  • [22] OPC-31260 - A NONPEPTIDE ORALLY ACTIVE V2 VASOPRESSIN RECEPTOR ANTAGONIST
    BURRELL, LM
    PHILLIPS, PA
    STEPHENSON, J
    RISVANIS, J
    JOHNSTON, CI
    JOURNAL OF ENDOCRINOLOGY, 1992, 135 : P56 - P56
  • [23] Key amino acids of vasopressin V1a receptor responsible for the species difference in the affinity of OPC-21268
    Shinoura, H
    Take, H
    Hirasawa, A
    Inoue, K
    Ohno, Y
    Hashimoto, K
    Tsujimoto, G
    FEBS LETTERS, 2000, 466 (2-3) : 255 - 258
  • [24] CHARACTERIZATION OF A NOVEL AQUARETIC AGENT, OPC-31260, AS AN ORALLY EFFECTIVE, NONPEPTIDE VASOPRESSIN V2-RECEPTOR ANTAGONIST
    YAMAMURA, Y
    OGAWA, H
    YAMASHITA, H
    CHIHARA, T
    MIYAMOTO, H
    NAKAMURA, S
    ONOGAWA, T
    YAMASHITA, T
    HOSOKAWA, T
    MORI, T
    TOMINAGA, M
    YABUUCHI, Y
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 105 (04) : 787 - 791
  • [25] EFFECTS OF THE VASOPRESSIN ANTAGONIST OPC-21268 IN RAT AORTIC VASCULAR SMOOTH-MUSCLE CELLS
    LI, XM
    KRIBBEN, A
    WIEDER, ED
    TSAI, P
    SCHRIER, RW
    NEMENOFF, RA
    CLINICAL RESEARCH, 1993, 41 (01): : A79 - A79
  • [26] BLOCKING EFFECTS OF V1 (OPC-21268) AND V2 (OPC-31260) ANTAGONISTS ON THE NEGATIVE INOTROPIC RESPONSE TO VASOPRESSIN IN ISOLATED DOG HEART PREPARATIONS
    FURUKAWA, Y
    TAKAYAMA, S
    REN, LM
    SAWAKI, S
    INOUE, Y
    CHIBA, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1992, 263 (02): : 627 - 631
  • [27] The role of vasopressin in essential hypertension - Plasma levels and effects of the V-1 receptor antagonist OPC-21268 during different dietary sodium intakes
    Kawano, Y
    Matsuoka, H
    Nishikimi, T
    Takishita, S
    Omae, T
    AMERICAN JOURNAL OF HYPERTENSION, 1997, 10 (11) : 1240 - 1244
  • [28] BLOCKING EFFECTS OF OPC-21268 AND OPC-31260 (VASOPRESSIN V1-RECEPTOR AND V2-RECEPTOR ANTAGONISTS) ON VASOPRESSIN-INDUCED CONSTRICTIONS IN ISOLATED, PERFUSED DOG FEMORAL ARTERIES
    CHIBA, S
    TSUKADA, M
    JAPANESE JOURNAL OF PHARMACOLOGY, 1992, 59 (01): : 133 - 135
  • [29] EFFECT OF VASOPRESSIN V-1 (OPC-21268) AND V-2 (OPC-31260) ANTAGONISTS ON RENAL HEMODYNAMICS AND EXCRETORY FUNCTION
    NAKAMURA, T
    SAKAMAKI, T
    KURASHINA, T
    HOSHINO, J
    SATO, K
    ONO, ZP
    MURATA, K
    LIFE SCIENCES, 1994, 55 (04) : PL67 - PL72
  • [30] Effects of the nonpeptide V1 vasopressin receptor antagonist SR49059 in hypertensive patients
    Thibonnier, M
    Kilani, A
    Rahman, M
    DiBlasi, TP
    Warner, K
    Smith, MC
    Leenhardt, AF
    Brouard, R
    HYPERTENSION, 1999, 34 (06) : 1293 - 1300
12345